Aptamer Group PLC Ordinary Shares APTA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 0.88
- Day Range
- GBX 0.77–0.89
- 52-Week Range
- GBX 0.45–30.50
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 397.24 Mil
- Volume/Avg
- 19.8 Mil / 7.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.58
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 54
- Website
- https://www.aptamergroup.com
Valuation
|
Metric
|
APTA
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.67 |
Price/Sales | 0.58 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
APTA
|
|---|---|
Quick Ratio | 1.91 |
Current Ratio | 2.14 |
Interest Coverage | −60.91 |
Quick Ratio
APTA
Profitability
|
Metric
|
APTA
|
|---|---|
Return on Assets (Normalized) | −137.05% |
Return on Equity (Normalized) | −339.87% |
Return on Invested Capital (Normalized) | −201.24% |
Return on Assets
APTA
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Bngsxvgt | Xpm | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Cnkpsgky | Lxvmr | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Pqbtkjbn | Qddqgth | $97.8 Bil | |
MRNA
| Moderna Inc | Srvtdxm | Vxkl | $38.8 Bil | |
ARGX
| argenx SE ADR | Ylkhrpzk | Flpl | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Drpdzpsq | Vwxx | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Hlrwgxrc | Ggkqbw | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Smnhwtdv | Gcvwgz | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Yzgbsfkrgx | Vnfjtf | $12.5 Bil | |
INCY
| Incyte Corp | Nbbrgdl | Fpflwd | $11.5 Bil |